Vasogen Announces the Appointments of Dr. Ronald Cresswell and Dr. Calvin Stiller to Board of Directors

12-Jan-2006

Vasogen Inc. announced that Ronald M. Cresswell, Ph.D., Hon. D. Sc., F.R.S.E., and Calvin R. Stiller, C.M., O.ONT, M.D., F.R.C.P.(C), have been named to its Board of Directors. Both Dr. Cresswell, former Senior Vice President and Chief Scientific Officer of Warner-Lambert, and Dr. Stiller, co-founder and former Chairman and CEO of the Canadian Medical Discoveries Fund, have considerable experience directing the research, development, and business initiatives of companies commercializing products for the healthcare industry.

Dr. Ronald Cresswell brings over 30 years of research and commercial development experience in cardiovascular and other important therapeutic areas to Vasogen's Board of Directors. Dr. Cresswell, the former Senior Vice President and Chief Scientific Officer of Warner-Lambert, began his tenure with Warner-Lambert in 1988 as the President of Research and Development of the Parke-Davis Pharmaceutical Research Division. From 1989-1998, he served as Vice President and Chairman of the Parke-Davis Worldwide Pharmaceutical Research Division. Dr. Cresswell joined Warner-Lambert from Laporte Industries, Ltd., where he was Chief Operating Officer. Prior to this, Dr. Cresswell was with Burroughs Wellcome for over twenty years. Dr. Cresswell has served on the Board of Directors of Esperion Therapeutics, Inc., Allergan, Inc., and Curagen Corporation.

Dr. Calvin Stiller brings a strong background in medicine and immunology to Vasogen's Board of Directors and has extensive experience in developing new therapeutics for a broad range of disease targets. He is currently a Professor of Medicine, and a Professor in the Microbiology and Immunology Department at the University of Western Ontario. Dr. Stiller established the Multi-Organ Transplant Service in London, Ontario, and served as the unit's chief from 1984 to 1996. Dr. Stiller is the co-founder of four healthcare funds. He was a Member of the Council and Executive Committee of the Medical Research Council of Canada (1987-1993) and is currently the Chair of the Ontario Research and Development Challenge Fund and a Board Member of the Ontario Innovation Trust. Dr. Stiller serves on the Board of Directors of NPS Pharmaceuticals, Inc., Spectral Diagnostics Inc., Residence Retirement REIT, and CPL Trust and several public endeavors and foundations, including Genome Canada (Chair), MARS (Medical and Related Sciences Discovery District), and OCRN (Ontario Cancer Research Network). He is also the recipient of numerous awards including the MEDEC Award, the Order of Canada, and the Order of Ontario. In May 2002, Dr. Stiller received an Honourary Doctor of Laws Degree from McMaster University in Hamilton.

https://www.bionity.com/en/news/51551/vasogen-announces-the-appointments-of-dr-ronald-cresswell-and-dr-calvin-stiller-to-board-of-directors.html